Anthem said its new pharmacy benefit management company IngenioRx will “produce a total operating gain” of at least $800 million in 2020 with the PBM’s rollout ahead of expectations.
Anthem said its new pharmacy benefit management company IngenioRx will “produce a total operating gain” of at least $800 million in 2020 with the PBM’s rollout ahead of expectations.